Rifaximin in the treatment of hepatic encephalopathy
Hepatic Medicine: Evidence and Research · 2011
DOI: 10.2147/hmer.s11988 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hepatic Medicine: Evidence and Research, 2011. Verfasst von Maddalena Diana Iadevaia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internistica Clinica e Sperimentale, F Magrassi e A Lanzara, Hepatogastroenterology Unit, Second University of Naples, Naples, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internistica Clinica e Sperimentale, F Magrassi e A Lanzara, Hepatogastroenterology Unit, Second University of Naples, Naples, Italy.
Zitieren
APA
Iadevaia, M. D., Prete, A. D., Cesaro, C., Gaeta, L., Zulli, C., & Loguercio, C. (2011). Rifaximin in the treatment of hepatic encephalopathy. Hepatic Medicine: Evidence and Research. https://doi.org/10.2147/hmer.s11988
Vancouver
Iadevaia MD, Prete AD, Cesaro C, Gaeta L, Zulli C, Loguercio C. Rifaximin in the treatment of hepatic encephalopathy. Hepatic Medicine: Evidence and Research. 2011. doi:10.2147/hmer.s11988
BibTeX
@article{Iadevaia2011,
author = {Iadevaia, Maddalena Diana and Prete, Anna Del and Cesaro, Claudia and Gaeta, Laura and Zulli, Claudio and Loguercio, Carmelina},
title = {Rifaximin in the treatment of hepatic encephalopathy},
journal = {Hepatic Medicine: Evidence and Research},
year = {2011},
doi = {10.2147/hmer.s11988}
}
EUVIMED